NCT02642653View on ClinicalTrials.gov

Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Fragile X SyndromeGenetic Diseases
Interventions
DRUG

Lovastatin

Once per day dosing

OTHER

Placebo

Once per day dosing

Trial Locations (1)

95817

UC Davis MIND Institute, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02642653 - Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome | Biotech Hunter | Biotech Hunter